In last trading session, Compugen Ltd (NASDAQ:CGEN) saw 0.34 million shares changing hands with its beta currently measuring 2.52. Company’s recent per share price level of $1.39 trading at $0.02 or 1.46% at ring of the bell on the day assigns it a market valuation of $129.98M. That closing price of CGEN’s stock is at a discount of -91.37% from its 52-week high price of $2.66 and is indicating a premium of 18.71% from its 52-week low price of $1.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.24 million shares which gives us an average trading volume of 280.03K if we extend that period to 3-months.
For Compugen Ltd (CGEN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Compugen Ltd (NASDAQ:CGEN) trade information
Upright in the green during last session for gaining 1.46%, in the last five days CGEN remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $1.39 price level, adding 2.8% to its value on the day. Compugen Ltd’s shares saw a change of -9.15% in year-to-date performance and have moved 10.32% in past 5-day. Compugen Ltd (NASDAQ:CGEN) showed a performance of -4.14% in past 30-days. Number of shares sold short was 1.72 million shares which calculate 6.88 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 4 to the stock, which implies a rise of 65.25% to its current value. Analysts have been projecting 4 as a low price target for the stock while placing it at a high target of 4. It follows that stock’s current price would drop -187.77% in reaching the projected high whereas dropping to the targeted low would mean a loss of -187.77% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.03% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 35.42% while estimates for its earnings growth in next 5 years are of 29.25%.
Compugen Ltd (NASDAQ:CGEN)’s Major holders
Insiders are in possession of 2.12% of company’s total shares while institution are holding 18.14 percent of that, with stock having share float percentage of 18.53%. Investors also watch the number of corporate investors in a company very closely, which is 18.14% institutions for Compugen Ltd that are currently holding shares of the company. SILVERARC CAPITAL MANAGEMENT, LLC is the top institutional holder at CGEN for having 1.5 million shares of worth $2.52 million. And as of 2024-06-30, it was holding 1.6766 of the company’s outstanding shares.
The second largest institutional holder is TAYLOR FRIGON CAPITAL MANAGEMENT LLC, which was holding about 1.31 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.4681 of outstanding shares, having a total worth of $2.21 million.
On the other hand, ARK ETF Trust-ARK Israel Innovative Technology ETF and Delaware Group Equity Funds IV-Macquarie Healthcare Fund are the top two Mutual Funds which own company’s shares. As of Apr 30, 2025 , the former fund manager was holding 1.09 shares of worth $1.51 million or 1.21% of the total outstanding shares. The later fund manager was in possession of 1.02 shares on Dec 31, 2024 , making its stake of worth around $1.42 million in the company or a holder of 1.14% of company’s stock.
